UKMi Pandemic Flu |

Information

Introduction

This section of the UKMi website provides access to material produced by UKMi and other bodies relating to seasonal and H1N1  influenza, with a focus on the current outbreak. These resources will be updated as the outbreak, and information related to it, develops. This section of the website will be suspended once the outbreak is no longer an active issue.

• Breastfeeding - oseltamivir and zanamivir  (updated 16/06/2009)   UKMi Medicines Q&A
• Drug interactions
  • Methotrexate - concomitant use with oseltamivir  (04/06/2009)  UKMi Medicines Q&A
  • Warfarin - interaction with oseltamivir and zanamivir  (12/09/2009)  UKMi Medicines Q&A
• Enteral feeding tubes - administration of oseltamivir via  (01/05/2009)  UKMi Medicines Q&A
• Immunocompromised patients - use of oseltamivir in  (29/05/2009)  UKMi Medicines Q&A
• PGDs - Local examples of PGDs for Pandemrix®, Celvepan® and trivalent seasonal flu vaccine  NeLM PGD portal
• Pregnancy  (UK Teratology Information Service - UKTIS) requires UKTIS registration
  • Seasonal flu vaccine (20/10/10) access to full guideline requires UKTIS registration
  • AH1N1v influenza vaccines (20/10/10) access to full guideline requires UKTIS registration
  • Management of pregnant women during an influenza A (H1N1) (Swine flu) pandemic  (16/12/10) access to full guideline requires UKTIS registration 
  • Oseltamivir (16/12/10) access to full guideline requires UKTIS registration 
  • Zanamivir (16/12/10)   access to full guideline requires UKTIS registration
• Renal impairment and with renal replacement therapies
  • Oseltamivir (26/10/2009)  UKMi Medicines Q&A
  • Zanamivir  (07/05/2009)  UKMi Medicines Q&A

• Fact sheet on Tamiflu (oseltamivir)  (updated 24/11/2010)  NHS Direct Medicines Fact Sheet 
• Fact sheet on Relenza (zanamvir)  (updated 27/07/2009)  NHS Direct Medicines Fact Sheet 
• Fact sheet on 2010 seasonal flu vaccination (updated 24/12/10) NHS Direct Medicines Fact Sheet
  

---

Other sources

• Health Protection Agency
  • Pharmacological treatment and prophylaxis of influenza V1.7 (12 January 2011)
    
    
•  Department of Health - 2010/11
  • Influenza season 2010/11 - use of antivirals in primary care (10 December 2010)
  • Treatment guidelines for patients with influenza 2010/2011 in secondary care (14 December 2010)

  • Flu vaccination for pregnant women (16 December 2010)

  • Seasonal flu vaccination for pregnant women clarification of advice in the Green Book (23 December 2010)

  • 2010/11 Seasonal influenza: prescription of antivirals - CMO letter (21 December 2010)
  • Vaccine Update Special news alert edition: seasonal flu vaccination (December 2010)
  • Supply and availability of antivirals for children under 1 year of age - CPhO letter (January 2011)
    
  • Seasonal flu vaccine uptake and vaccine supply - CMO letter (6 January 2011)
    
• Department of Health - 2009 archive
  • Pandemic H1N1 2009 influenza: Clinical management guidelines for pregnancy (Oct 2009)

  • Pandemic H1N1 2009 influenza: Clinical management guidelines for adults and children (Oct 2009)

  • Clinical professionals brief on swine flu vaccination (28/10/2009)

  • Pregnancy, Breastfeeding and Swine Flu A/H1N1

  • Dosage of oseltamivir in children under one year of age with swine flu (24/09/2009
    
    

• MHRA

  • UK ADR analysis. Influenza antivirals - oseltamivir (Tamiflu) and zanamivir (Relenza) (4 February 2010)

  • Safety review of pandemic vaccines and antivirals (Drug Safety Update October 2010)

  • Seasonal flu vaccines and risk of febrile convulsions in children (December 2010)
    
    

NHS Choices

Royal Pharmaceutical Society

• Seasonal influenza web resource for pharmacists

---

Medicines information provision in the event of a critical influenza outbreak

These two guidelines support UKMi local and regional services plan to deliver service continuity in the event of a critical influenza outbreak.  They are intended as a guide only as circumstances will vary according to local conditions and service priorities.

• Advice for provider Chief Pharmacists and their teams
• Availability of regional services
• Guidance on prioritising work for regional services